Evidence map›Paper›PMID 39576011›Full record

ArticleJCI insight2024

STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis.

Jazib Uddin, Ankit Sharma, David Wu, Sunil Tomar, Varsha Ganesan, Paula E Reichel, Lakshmi Narasimha Rao Thota, Rodolfo I Cabrera-Silva, Sahiti Marella, Gila Idelman and 14 more

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jazib UddinDivision of Experimental Pathology, Department of Pathology, and.
Ankit SharmaDivision of Experimental Pathology, Department of Pathology, and.
David WuDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Sunil TomarDivision of Experimental Pathology, Department of Pathology, and.
Varsha GanesanDivision of Experimental Pathology, Department of Pathology, and.
Paula E ReichelDivision of Experimental Pathology, Department of Pathology, and.
Lakshmi Narasimha Rao ThotaDivision of Experimental Pathology, Department of Pathology, and.
Rodolfo I Cabrera-SilvaDivision of Experimental Pathology, Department of Pathology, and.
Sahiti MarellaDivision of Experimental Pathology, Department of Pathology, and.
Gila IdelmanDivision of Experimental Pathology, Department of Pathology, and.
Hock L TayDivision of Experimental Pathology, Department of Pathology, and.
Arturo Raya-SandinoDivision of Experimental Pathology, Department of Pathology, and.
Mack B ReynoldsGraduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Srikanth EleselaDivision of Experimental Pathology, Department of Pathology, and.
Yael HabermanSheba Medical Center, Tel-Hashomer, and.
Lee A DensonDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Charles A ParkosDivision of Experimental Pathology, Department of Pathology, and.
Mary Xd O'RiordanDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Nicholas W LukacsDivision of Experimental Pathology, Department of Pathology, and.
David N O'DwyerDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Senad DivanovicDivision of Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Asma NusratDivision of Experimental Pathology, Department of Pathology, and.
Timothy E WeaverDivisions of Neonatology, Perinatal Biology, and Pulmonary Biology, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Simon P HoganDivision of Experimental Pathology, Department of Pathology, and.

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Immunopathogenesis of Non-alcoholic Fatty Liver DiseaseR01DK099222 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Senad Divanovic · 2013 to 2026
$5.6M
Food Allergy and Goblet Cell Antigen PassagesR01AI112626 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOGAN, SIMON PATRICK, NEWBERRY, RODNEY D · 2015 to 2019
$2.4M
Pro-Type 2 Goblet Cell Antigen Passages in Food Sensitization and ReactivityR37AI112626 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SIMON Patrick HOGAN, Rodney D Newberry · 2023 to 2026
$2.2M
Eosinophil:M2 Macrophage:CCL11 Axis in Experimental Colitis and Pediatric CorticoR01DK090119 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI HOGAN, SIMON PATRICK · 2012 to 2015
$1.3M
Intestinal epithelial immunological responses and food allergen samplingR21AI138177 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOGAN, SIMON PATRICK · 2019 to 2020
$429k
The Regulatory Role of PIRB in CD4+ Th17 Mediated ColitisF31DK125007 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI UDDIN, JAZIB NASEER · 2020 to 2021
$76k
NIAID NIH HHS R01 AI112626NIAID NIH HHS R21 AI138177NIAID NIH HHS R37 AI112626NIAID NIH HHS T32 AI007413NIDDK NIH HHS F31 DK125007NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK090119NIDDK NIH HHS R01 DK099222
6 · The paper itself

Abstract

Susceptibility to inflammatory bowel diseases (IBDs), Crohn's disease (CD), and ulcerative colitis (UC) is linked with loss of intestinal epithelial barrier integrity and mitochondria dysfunction. Steroidogenic acute regulatory (StAR) protein-related lipid transfer (START) domain-containing protein 7 (STARD7) is a phosphatidylcholine-specific (PC-specific) lipid transfer protein that transports PC from the ER to the mitochondria, facilitating mitochondria membrane stabilization and respiration function. The aim of this study was to define the contribution of STARD7 in the regulation of the intestinal epithelial mitochondrial function and susceptibility to colitis. In silico analyses identified significantly reduced expression of STARD7 in patients with UC, which was associated with downregulation of metabolic function and a more severe disease phenotype. STARD7 was expressed in intestinal epithelial cells, and STARD7 knockdown resulted in deformed mitochondria and diminished aerobic respiration. Loss of mitochondria function was associated with reduced expression of tight junction proteins and loss of intestinal epithelial barrier integrity that could be recovered by AMPK activation. Stard7+/- mice were more susceptible to the development of DSS-induced and Il10-/- spontaneous models of colitis. STARD7 is critical for intestinal epithelial mitochondrial function and barrier integrity, and loss of STARD7 function increases susceptibility to IBD.

Indexed as

Intestinal MucosaMitochondriaAnimalsCarrier ProteinsColitisColitis, UlcerativeDisease Models, AnimalEpithelial CellsFemaleHumansInterleukin-10MaleMiceMice, Inbred C57BLMice, KnockoutCarrier ProteinsInterleukin-10InflammationInflammatory bowel diseaseMitochondria

Identifiers

PMID39576011
PMCPMC11601949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.